the future of aml and mds diagnosis and treatment
Published 6 years ago • 322 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:02
bispecific agents: the future of aml and mds treatment?
-
3:37
the future of aml treatment
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
2:43
novel therapies in the future of mds treatment
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
1:44
the future of aml therapy
-
1:13
the importance of cd47 as a target in mds and aml
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
3:31
alz-801 phase ii data & launch of phase iii study in early alzheimer’s disease
-
1:12:19
early feasibility studies (efs) round table
-
4:48
managing and treating mds
-
1:30
aml & myelodysplasia breakthrough
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
1:04
the future of mds management
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
1:21
future treatment priorities for high-risk mds
-
1:50
phase ii study of vibecotamab in mrd aml and mds & cmml after hma failure
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
3:14
hypomethylating agents in mds and aml
-
1:21
what is the future of aml treatment? #aml
-
2:16
current and future treatment approaches for hr-mds
-
2:09
advances in the management of fit adults with aml